AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
Matthias Zurbinsky moderates a panel at the Psychedelics Therapeutic and Drug Development Conference in San Francisco. He talks with three VCs about what it really takes for a traditional biotech VC to fund a psychedelic company. The idea is that we need larger sources of funding, as well as people who are very experienced both on translational science and bringing a drug to the clinic.